Drug General Information
Drug ID	D01FCK
Former ID	DIB008002
Drug Name	Teglicar
Synonyms	Reversible palmitoyltransferase inhibitor; ST-1326
Drug Type	Small molecular drug
Indication	Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1]		Discontinued in Phase 2	[547517]
Company	Sigma-Tau SpA
Structure		Download 2D MOL 3D MOL
Formula	C22H45N3O3
Canonical SMILES	[C@H](NC(=O)NCCCCCCCCCCCCCC)(C[N+](C)(C)C)CC(=O)[O-]
CAS Number	CAS 250694-07-6
PubChem Compound ID	9843897
Target and Pathway
Target(s)	Carnitine acyltransferase	Target Info	Inhibitor	[544162]
References
Ref 547517	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017026)
Ref 544162	Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis. Diabetes. 2011 February; 60(2): 644-651.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.